You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Over the next three years, the company and its partners will assess the OneRNA platform to diagnose bladder cancer, select treatment, and measure response and recurrence.
The companies are planning to develop individual disease diagnostics, and then a universal diagnostic from a single blood test.
With computing infrastructure in place, Nationwide Children's Hospital's Institute for Genomic Medicine is giving clinicians new tools for diagnosis and treatment.
The Ontario Institute of Cancer Research-hosted Cancer Genome Collaboratory has amassed 650 TB of data and supported early discovery of mutations.
Commercialization efforts will focus on the most recent version of Genialis' platform, which includes tools for RNA-seq analysis and variant discovery.
Inova Translational Medicine Institute has become more efficient running Cloudera's platform, but continues to evaluate this new world of bioinformatics.
Under the partnership, DNAnexus customers will have direct access to the Dragen Genome Pipeline for "ultra-rapid" genome analysis.
Geneformics, which grew out of Israel's Weizmann Institute, promises to boost the speed of moving data by tenfold and cut costs by 90 percent.
The SolarGenomics platform, built on the public Alibaba cloud and Annoroad's private hardware, offers analysis pipelines, storage, and laboratory management software.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.
The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.
About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.
In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.